Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

HPQ's Q4 Earnings Beat Estimates, Revenues Increase Y/Y
HPQ's Q4 Earnings Beat Estimates, Revenues Increase Y/Y

HP Inc. HPQ reported fourth-quarter fiscal 2025 earnings of 93 cents per share, which beat the Zacks Consensus Estimate by 2.2%. The company reported earnings of 96 cents per share a year ago. These

Procter & Gamble vs. Church & Dwight: Which Household Stock Outshines?
Procter & Gamble vs. Church & Dwight: Which Household Stock Outshines?

In the world of household and personal care, two giants stand on opposite ends of a competitive battlefield — The Procter & Gamble Company PG and Church & Dwight Co., Inc. CHD. PG is the

Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 110.27%: Here's is How to Trade
Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 110.27%: Here's is How to Trade

Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Think PRA Group (PRAA) Could Surge 41.95%: Read This Before Placing a Bet
Wall Street Analysts Think PRA Group (PRAA) Could Surge 41.95%: Read This Before Placing a Bet

PRA Group (PRAA) closed the last trading session at $15.97, gaining 9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet

Amicus Therapeutics (FOLD) closed the last trading session at $9.87, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade
Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade

Shares of Compass Therapeutics, Inc. (CMPX) have gained 22.2% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe Crexendo (CXDO) Could Rally 27.87%: Here's is How to Trade
Wall Street Analysts Believe Crexendo (CXDO) Could Rally 27.87%: Here's is How to Trade

Shares of Crexendo (CXDO) have gained 8.6% over the past four weeks to close the last trading session at $6.96, but there could still be a solid upside left in the stock if short-term price targets

Does SkyWest (SKYW) Have the Potential to Rally 34.49% as Wall Street Analysts Expect?
Does SkyWest (SKYW) Have the Potential to Rally 34.49% as Wall Street Analysts Expect?

Shares of SkyWest (SKYW) have gained 0.7% over the past four weeks to close the last trading session at $99.34, but there could still be a solid upside left in the stock if short-term price targets

Should You Buy PLBY Group, Inc. (PLBY) After Golden Cross?
Should You Buy PLBY Group, Inc. (PLBY) After Golden Cross?

From a technical perspective, PLBY Group, Inc. (PLBY) is looking like an interesting pick, as it just reached a key level of support. PLBY's 50-day simple moving average crossed above its 200-day

Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet

Shares of OrthoPediatrics (KIDS) have gained 12.9% over the past four weeks to close the last trading session at $19.09, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade

Shares of Pharming Group N.V. Sponsored ADR (PHAR) have gained 24% over the past four weeks to close the last trading session at $17.06, but there could still be a solid upside left in the stock if

Wall Street Analysts Predict a 46.55% Upside in Life Time Group Holdings (LTH): Here's  What You Should Know
Wall Street Analysts Predict a 46.55% Upside in Life Time Group Holdings (LTH): Here's What You Should Know

Life Time Group Holdings, Inc. (LTH) closed the last trading session at $27.54, gaining 7.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts See a 126.21% Upside in Immuneering (IMRX): Can the Stock Really Move This High?
Wall Street Analysts See a 126.21% Upside in Immuneering (IMRX): Can the Stock Really Move This High?

Shares of Immuneering Corporation (IMRX) have gained 14.6% over the past four weeks to close the last trading session at $7.44, but there could still be a solid upside left in the stock if

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%
How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%

Shares of Keros Therapeutics, Inc. (KROS) have gained 14.1% over the past four weeks to close the last trading session at $17.32, but there could still be a solid upside left in the stock if

Bears are Losing Control Over ClearSign (CLIR), Here's Why It's a 'Buy' Now
Bears are Losing Control Over ClearSign (CLIR), Here's Why It's a 'Buy' Now

Shares of ClearSign Technologies (CLIR) have been struggling lately and have lost 8.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean

Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?
Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?

Akamai Technologies, Inc. (AKAM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AKAM's 50-day simple moving average

Wall Street Analysts Believe Orion Energy Systems (OESX) Could Rally 26.36%: Here's is How to Trade
Wall Street Analysts Believe Orion Energy Systems (OESX) Could Rally 26.36%: Here's is How to Trade

Orion Energy Systems, Inc. (OESX) closed the last trading session at $14.11, gaining 41.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Affiliated Managers Group (AMG) is a Top-Ranked Momentum Stock: Should You Buy?
Affiliated Managers Group (AMG) is a Top-Ranked Momentum Stock: Should You Buy?

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Paymentus (PAY) is a Strong Momentum Stock
Here's Why Paymentus (PAY) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why FMC Technologies (FTI) is a Strong Momentum Stock
Here's Why FMC Technologies (FTI) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?
Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why New York Times Co. (NYT) is a Strong Momentum Stock
Here's Why New York Times Co. (NYT) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different